In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Esteve gets European rights to Wex's tetrodotoxin products

Executive Summary

Spanish pharma Laboratorios del Dr. Esteve SA has licensed European rights to International Wex Technologies' (pain management, drug addiction, and anesthesia) tetrodotoxin products in development--Tectin, Tetrodin, and Tocudin, and future formulations of the pharmaceuticals.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies